Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells

Oral Oncology

Volumn 41, Issue 6, 2005, Pages 623-630

  Harada, Koji ^a   Supriatno, ^a   Kawashima, Yuichiro ^a   Itashiki, Yasutaka ^a   Yoshida, Hideo ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anti sense; Apoptosis; Oral cancer; Skp2

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; S PHASE KINASE ASSOCIATED PROTEIN 2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL NUCLEUS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; FRAGMENTATION REACTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOUTH CARCINOMA; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CASPASES; CELL DIVISION; DNA FRAGMENTATION; DNA, NEOPLASM; DOWN-REGULATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; S-PHASE KINASE-ASSOCIATED PROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 20444494063     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.02.007     Document Type: Article

References (25)

1. P. Pisani, D.M. Parkin, F. Bray, and J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 1999 18 29
2. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 1999 827 841
3. H. Zhang, R. Kobayashi, K. Galaktionov, and D. Beach p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase Cell 82 1995 915 925
4. A.C. Carrano, E. Eytan, A. Hershko, and M. Pagano Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1 1999 193 199
5. H. Sutterluty, E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, and U. Muller p45 (Skp2) promotes p27 (Kip1) degradation and induces S phase in quiescent cells Nat Cell Biol 1 1999 207 214
6. Kip1, polyploidy and centrosome overduplication EMBO J 19 2000 2069 2081
7. A. Marti, C. Wirbelauer, M. Scheffner, and W. Krek Interaction between ubiquitin-protein ligase SCFSkp2 and E2F-1 underlies the regulation of E2F-1 degradation Nat Cell Biol 1 1999 14 19
8. J. Mendez, X.H. Zou-Yang, S.Y. Kim, M. Hidaka, W.P. Tansey, and B. Stillman Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication Mol Cell 9 2002 481 491
9. E. Latres, R. Chiarlie, B.A. Schulman, N.P. Pavletich, A. Pellicer, and G. Inghirami Role of the F-box protein Skp2 in lymphomagenesis Proc Natl Acad Sci USA 98 2001 2515 2520
10. D. Hershko, G. Bornstein, O. Ben-Izhak, A. Carrano, M. Pagano, and M.M. Krausz Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinoma Cancer 91 2001 1745 1751
11. R. Chiarle, Y. Fan, R. Piva, H. Boggino, J. Skolnik, and D. Novero S-phase kinase- associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase Am J Pathol 160 2002 1457 1466
12. M. Gstaigert, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, and J. Slingerland Skp2 is oncogenic and overexpressed in human cancers Proc Natl Acad Sci USA 98 2001 5043 5048
13. Y. Kudo, S. Kitajima, S. Sato, M. Miyauchi, I. Ogawa, and T. Takata High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas Cancer Res 61 2001 7044 7047
14. T.A. Masuda, H. Inoue, H. Sonoda, S. Mine, Y. Yoshikawa, and K. Nakayama Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis Cancer Res 62 2002 3819 3825
15. S. Yokoi, K. Yasui, T. Lizasa, T. Takahashi, T. Fujisawa, and J. Inazawa Down-regulation of SKP2 induces apoptosis in lung-cancer cells Cancer Sci 94 2003 344 349
16. T. Yanagawa, Y. Hayashi, H. Yoshida, Y. Yura, S. Nagamine, and T. Bando An adenoid squamous cell carcinoma cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen Am J Pathol 124 1986 495 509
17. S. Kawaguchi, K. Harada, Supriatno, H. Yoshida, and M. Sato Overexpression of tuberous sclerosis complex 2 exerts antitumor effect on oral cancer cell lines Oral Oncol 39 2003 836 841
18. J. Carmichael, W.G. DeGraff, A.F. Gazdar, J.D. Minna, and J.B. Mitchell Evaluation of tetrazolium-based semiautomated calorimetric assay: assessment of chemosensitivity testing Cancer Res 47 1987 936 942
19. Kip1 Anticancer Res 23 2003 1441 1448
20. K. Harada, S. Kawaguchi, Supriatno, T. Onoue, H. Yoshida, and M. Sato Enhancement of apoptosis in salivary gland cancer cells by the combination of oral fluoropyrimidine anticancer agent (S-1) and radiation Int J Oncol 25 2004 905 911
21. Y. Gavrieli, and Y. Sherman Ben-Sasson: identification of programmed cell death in situ specific labeling of nuclear DNA fragmentation J Cell Biol 119 1992 493 500
22. Y. Katayose, M. Kim, A.N. Rakkar, Z. Li, K.H. Cowan, and P. Seth Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27 Cancer Res 57 1997 5441 5445
23. S. Yokoi, K. Yasui, F. Saito-Ohara, K. Koshikawa, T. Lizasa, and T. Fujisawa A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers Am J Pathol 161 2002 207 216
24. Kip1 and poor prognosis in oral squamous cell carcinoma Oncology 65 2003 355 362
25. J. Slingerland, and M. Pagano Regulation of the CDK inhibitor p27 and its deregulation in cancer J Cell Physiol 183 2000 10 17